RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PIRS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Pieris Pharmaceuticals stock still a buy after falling -5.42% on Thursday?
(Updated on Mar 28, 2024)

Buy candidate since Mar 26, 2024 Loss -2.55% PDF

The Pieris Pharmaceuticals stock price fell by -5.42% on the last day (Thursday, 28th Mar 2024) from $0.194 to $0.183. During the last trading day the stock fluctuated 5.08% from a day low at $0.183 to a day high of $0.193. The price has been going up and down for this period, and there has been a 7.13% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -838 thousand shares and in total, 393 thousand shares were bought and sold for approximately $72.04 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.37% during the next 3 months and, with a 90% probability hold a price between $0.174 and $0.233 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PIRS Signals & Forecast

The Pieris Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.194. On a fall, the stock will find some support from the long-term average at approximately $0.175. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 0.83%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pieris Pharmaceuticals stock

Pieris Pharmaceuticals finds support from accumulated volume at $0.182 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0093 between high and low, or 5.08%. For the last week the stock has had daily average volatility of 7.91%.

Our recommended stop-loss: $0.173 (-5.70%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (PIRS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Pieris Pharmaceuticals to open at $0.186, and during the day (based on 14 day Average True Range), to move between $0.163 and $0.203, which gives a possible trading interval of +/-$0.0201 (+/-10.99%) up or down from last closing price. If Pieris Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 21.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.182 (0.82%) than the resistance at $0.194 (5.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pieris Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pieris Pharmaceuticals stock to perform well in the short-term.

Current score: 3.472 Buy Candidate Unchanged

Predicted Opening Price for Pieris Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.186 ( 1.69%) $0.183

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PIRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.196 6.77 %
R2 0.192 4.83 %
R1 0.190 3.63 %
Current price: 0.183
Support S1 0.183 -0.247 %
S2 0.181 -1.45 %
S3 0.177 -3.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.216 17.63 %
R2 0.210 14.63 %
R1 0.194 5.73 %
Current price 0.183
Support S1 0.182 -0.82%
S2 0.172 -6.11%
S3 0.170 -7.15%

FAQ

What is the symbol for Pieris Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Pieris Pharmaceuticals is PIRS and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Pieris Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pieris Pharmaceuticals stock to perform well in the short-term.

How to buy Pieris Pharmaceuticals Stock?
Pieris Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pieris Pharmaceuticals Stock.

What's the current price of Pieris Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Pieris Pharmaceuticals (PIRS) share was $0.183.

What is the 52-week high and low for Pieris Pharmaceuticals Stock?
The 52-week high for Pieris Pharmaceuticals Stock is $1.29 and the 52-week low is $0.136.

What is the market capitalization of Pieris Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Pieris Pharmaceuticals is 18.11M.

When is the next earnings date for Pieris Pharmaceuticals?
The upcoming earnings date for Pieris Pharmaceuticals is Apr 03, 2024.
Click to get the best stock tips daily for free!

About Pieris Pharmaceuticals

Pieris Pharmaceuticals Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate ... PIRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT